<DOC>
	<DOC>NCT00117338</DOC>
	<brief_summary>This study will attempt to find out if the addition of an intravenous form of a drug that is already used for treating asthma in children will help resolve asthma attacks faster than using the current standard care alone.</brief_summary>
	<brief_title>A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)</brief_title>
	<detailed_description>The duration of treatment is a one time dose.</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Children 614 years of age seeking treatment in emergency departments with acute asthma attacks Other respiratory conditions (including congenital lung abnormalities) or other acute illnesses that would complicate current treatment and response for asthma</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>